Cervical cancer is the second most common cancer in women in India, according to Indian Council of Medical Research data.
Cervical Cancer Chemotherapy: — Cisplatin and Chemoradiation Regimens
Cisplatin given alongside radiation is the standard treatment for locally advanced cervical cancer. For disease that has spread or returned, cisplatin-based combinations are used differently — as systemic therapy reaching cancer cells throughout the body. This page explains how each approach works and what the treatment involves.
- Two different settings — Cisplatin works differently depending on whether the cancer is locally advanced or has spread — the regimen is not the same in both situations.
- Chemoradiation for most — For locally advanced cervical cancer, cisplatin is given as a weekly infusion during weeks of radiation — not as a stand-alone treatment.
- Combinations for spread disease — When cancer has spread or returned, cisplatin is combined with another drug — typically paclitaxel — and sometimes a third agent is added.
- Alternatives exist — Carboplatin can replace cisplatin when kidney function or hearing loss makes cisplatin unsuitable for a particular patient.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed September 2026
Cisplatin is the standard chemotherapy for cervical cancer. In locally advanced disease, it is given weekly during radiation — a combination called concurrent chemoradiation — recommended by NCCN, ESMO, and ASCO. For recurrent or metastatic disease, cisplatin is paired with paclitaxel, with or without bevacizumab.
What is the standard chemotherapy regimen for cervical cancer?
For locally advanced cervical cancer — broadly, tumours that have grown beyond the cervix but have not spread to distant sites — the standard approach combines chemotherapy with radiotherapy given at the same time. This is called concurrent chemoradiation.
Cisplatin is given as an intravenous infusion once a week, during the same weeks that you are also receiving external beam radiotherapy.
Cisplatin acts as a radiosensitiser in this setting: it makes cancer cells more sensitive to the radiation they are receiving, so the two treatments reinforce each other.
NCCN, ESMO, and ASCO guidelines all identify weekly cisplatin-based concurrent chemoradiation as the preferred approach for locally advanced cervical cancer.
What regimens are used when cervical cancer has spread or come back?
When cervical cancer has spread to distant sites, or has returned after initial treatment, chemotherapy is used as systemic therapy — reaching cancer cells throughout the body rather than sensitising a local area to radiation.
The combination of cisplatin and paclitaxel is a primary regimen for this setting. Bevacizumab — a drug that targets blood vessel growth in tumours — may be added, and this three-drug combination is reflected in current NCCN and ASCO guidance.
When cisplatin is not suitable for a particular patient, carboplatin and paclitaxel may be used instead. Carboplatin belongs to the same platinum family as cisplatin but has a different side-effect profile.
For patients whose tumours test positive for the PD-L1 protein, pembrolizumab — an immunotherapy drug — may be added to a chemotherapy backbone. This is addressed in current NCCN, ASCO, and ESMO guidance for eligible patients.
Who these chemotherapy regimens are not for
These regimens are not appropriate for all patients with cervical cancer. Eligibility is always decided by an oncologist based on the individual case.
- Early-stage disease managed with surgery: Stage IA1 and some stage IA2 and IB1 tumours are treated surgically without chemotherapy.
- Significantly impaired kidney function: Cisplatin is processed through the kidneys and is avoided when kidney function is substantially reduced. Carboplatin may be considered as an alternative in some cases.
- Pre-existing significant hearing loss: Cisplatin can cause hearing damage, so it is used with care where hearing loss is already present.
- Allergy to platinum compounds: Both cisplatin and carboplatin belong to the platinum family. A known allergy to this class may rule out both drugs.
- Pregnancy: Chemotherapy carries risk to the developing fetus. Use during pregnancy requires detailed specialist discussion.
Did you know?
In Telangana and Andhra Pradesh, rates sit among the highest in the country — which is part of why understanding these regimens by name matters for patients and families across this region.
Source: Indian Council of Medical Research (ICMR) – National Cancer Registry Programme
What else should you know about these regimens?
What exactly is concurrent chemoradiation?
It means chemotherapy and radiotherapy are given during the same period, not one after the other. In cervical cancer, cisplatin is given as an intravenous infusion once a week during the weeks of radiotherapy — so both treatments are active at the same time. Cisplatin does not treat the cancer on its own in this setting. Its role is to make cancer cells more sensitive to the radiation they are receiving, so the radiation does more damage to the tumour than it would alone.
How many cycles of chemotherapy is usual during chemoradiation?
The number of cisplatin infusions depends on how many weeks of external beam radiotherapy your plan includes and how well your body tolerates the drug. Cisplatin is given once a week during the radiotherapy weeks, so the number of infusions corresponds roughly to the number of radiotherapy weeks. Your oncologist will tell you the expected number at the start of your plan and will describe it as a typical range rather than a promise — because dose adjustments and delays can happen based on how your body responds.
Where does brachytherapy fit into the treatment?
Brachytherapy is a form of radiotherapy where a radioactive source is placed directly inside or close to the cervix, delivering a high dose of radiation precisely to the tumour site. It is given after the course of external beam radiotherapy and concurrent cisplatin is complete — the two phases are sequential, not simultaneous. Together, external beam radiotherapy and brachytherapy make up the full radiation treatment for locally advanced cervical cancer, and the cisplatin phase runs only during the external beam weeks.
What are the main side effects of cisplatin to be aware of?
Cisplatin can affect the kidneys, because it is processed and cleared through the renal system. Kidney function is checked with blood tests before each infusion. Nausea and vomiting are common and are managed with anti-nausea medicines given alongside the cisplatin. Hearing changes — particularly difficulty hearing high-pitched sounds — are a recognised effect of cisplatin and can be lasting. Tingling or numbness in the fingers and toes, known as peripheral neuropathy, is also possible with repeated doses. Your oncology team will monitor for all of these and explain what to watch for at home.
Why might my oncologist choose carboplatin instead of cisplatin?
Carboplatin is the most commonly used alternative when cisplatin is not tolerated or not suitable. Reasons your oncologist might choose carboplatin include reduced kidney function — since cisplatin is harder on the kidneys — significant pre-existing hearing loss, or poor tolerance from prior cisplatin treatment. Carboplatin belongs to the same platinum drug family as cisplatin but has a somewhat different side-effect pattern. The choice between them is made by your oncologist based on your blood tests, any hearing assessment, and your overall fitness at the time treatment is planned.
Explore 82 more How Chemotherapy Is Given: Regimens, Cycles & Infusion Days topics
Chemotherapy Regimens by Name
- 7+3 and Induction Regimens for Acute Leukaemia
- ABVD Regimen for Hodgkin Lymphoma
- AC and EC Regimens
- AC-T Regimen for Breast Cancer
- BEP Regimen for Testicular and Germ Cell Cancer
- CAPOX and XELOX Regimens
- CHOP Without Rituximab
- Carboplatin-Paclitaxel Regimen
- Cervical Cancer Chemotherapy and Chemoradiation Regimens
- Chemotherapy Regimens: What the Acronyms Mean
- Cisplatin-Pemetrexed and Platinum-Pemetrexed
- Comparing Two Regimens: How the Choice Is Made
- DCF and FLOT Regimens for Stomach Cancer
- Doxorubicin-Ifosfamide and Sarcoma Regimens
- EP and Carboplatin-Etoposide for Small Cell Lung Cancer
- FEC and CMF Regimens
- FOLFIRI Regimen
- FOLFIRINOX and Modified FOLFIRINOX
- FOLFOX Regimen for Colorectal Cancer
- GemCis and MVAC for Bladder Cancer
- Gemcitabine-Nab-Paclitaxel for Pancreatic Cancer
- R-CHOP Regimen for Lymphoma
- Salvage Lymphoma Regimens: ICE, DHAP and ESHAP
- TC Regimen (Docetaxel and Cyclophosphamide)
- TPF and Cisplatin Regimens for Head and Neck Cancer
- VRd, VCd and Myeloma Regimens
- Weekly Cisplatin With Radiation (Chemoradiation)
- Which Regimen Is Used for Which Cancer?
Cycle Delays, Dose Reductions & Changes
- Does a Delay Mean the Cancer Is Growing?
- Does a Reduced Dose Still Work?
- Growth Factor Support to Keep the Schedule
- How Many Delays Are Too Many?
- Infection Delaying a Cycle
- My Counts Were Too Low and the Cycle Was Postponed
- Organ Function Problems Delaying a Cycle
- Stopping Early: What Happens If You Do Not Complete the Course?
- Transfusion During Chemotherapy
- What If I Cannot Tolerate the Treatment?
- What Is a Dose Reduction and Why Was Mine Reduced?
- What to Ask If Your Plan Changes
- Why Chemotherapy Gets Delayed or Reduced
- Why Was My Regimen Switched?
HUB — Chemotherapy Regimens
HUB — Cycles, Schedules and What Happens on Infusion Day
How Chemotherapy Is Given
- Can Chemotherapy Be Given at Home?
- Can Chemotherapy Be Given at a Local Hospital?
- Continuous Infusion Chemotherapy and Portable Pumps
- Day Care vs Admission for Chemotherapy
- How Is Chemotherapy Given? All the Routes Explained
- How Long Does Each Chemotherapy Session Take?
- Intra-Arterial and Regional Chemotherapy
- Intraperitoneal Chemotherapy
- Intrathecal Chemotherapy: Into the Spinal Fluid
- Intravenous Chemotherapy: What the Drip Involves
- Intravesical Chemotherapy for the Bladder
- Is Oral Chemotherapy Weaker Than Injections?
- Oral Chemotherapy: Tablets Instead of a Drip
- Subcutaneous and Intramuscular Chemotherapy
- Topical Chemotherapy Creams
- What Safety Checks Happen Before Each Dose?
- Who Actually Gives Your Chemotherapy?
- Why Does the Route Sometimes Change During Treatment?
Regimens, Cycles & Schedules
- A Printable Chemotherapy Cycle Calendar
- Adding or Removing Cycles Mid-Course
- Blood Tests Before Every Cycle: What They Check
- Day 1, Day 8, Day 15: What the Day Numbers Mean
- Does Delaying a Cycle Reduce the Benefit?
- How Many Cycles Before the First Assessment?
- How the Dose Is Calculated for You
- Keeping a Chemotherapy Symptom Diary
- Planning Your Life Around Chemotherapy Cycles
- Rescheduling or Missing a Chemotherapy Appointment
- Weekly, Two-Weekly and Three-Weekly Schedules
- What Happens Between Cycles?
- What Happens at the Last Cycle?
- What Is Dose Intensity?
- What Is a Chemotherapy Cycle?
- What Is the Nadir and Why Does It Matter?
- Which Days of the Cycle Will I Feel Worst?
- Why Was My Cycle Postponed?
The Infusion Day
Your First Cycle
All How Chemotherapy Is Given: Regimens, Cycles & Infusion Days →
Frequently asked questions
Does everyone with cervical cancer need chemotherapy?
Not everyone. Early-stage cervical cancer — such as stage IA1 and some IA2 and IB1 tumours — is often treated with surgery alone, without chemotherapy. Chemotherapy becomes part of the treatment plan for locally advanced disease, and it is used systemically for recurrent or metastatic disease. Whether you need it, and in what form, depends on the stage at diagnosis, the size and position of the tumour, and your overall fitness. Your oncologist will explain which applies to your situation.
Why is cisplatin given with radiation rather than on its own?
Cisplatin acts as a radiosensitiser — it makes cancer cells more vulnerable to radiation damage. When both are given at the same time, the radiation is more effective than it would be alone. This is why, for locally advanced cervical cancer, the two treatments are run concurrently rather than in sequence. Giving cisplatin alone, without radiation, is not the standard approach in this setting; its role here is specifically to enhance what the radiation does.
How long does the full chemoradiation treatment take?
The concurrent chemoradiation phase runs across the weeks of external beam radiotherapy, with cisplatin given once a week during that time. Brachytherapy follows after this phase completes. Your radiation oncologist will give you a specific schedule at the start of treatment and explain the total expected duration for your plan. The schedule varies between patients, and your team will tell you what to expect in your individual case.
What if I cannot have cisplatin — is there an alternative?
Carboplatin is the most commonly used alternative when cisplatin is not suitable. Both drugs belong to the platinum family and work in a similar way, but carboplatin is less likely to cause kidney damage and carries a lower risk of hearing problems. It is combined with paclitaxel in the systemic regimens for recurrent and metastatic disease. The decision to use carboplatin instead of cisplatin is based on your kidney function, existing hearing test results, and treatment history — your oncologist will assess this and explain the choice.
Can immunotherapy be used for cervical cancer?
Pembrolizumab, an immunotherapy drug that targets the PD-1 pathway, has been incorporated into systemic treatment for recurrent or metastatic cervical cancer in patients whose tumours test positive for PD-L1. This addition to the chemotherapy backbone is addressed in current NCCN, ASCO, and ESMO guidance for eligible patients. Whether pembrolizumab applies to you depends on your tumour biology, prior treatment, and overall fitness — your oncologist will assess this alongside any biomarker testing done on your tumour.
Will my hair fall out during these treatments?
It depends on which drugs are part of your regimen. Paclitaxel, which is used in the systemic regimens for recurrent or metastatic disease, typically causes significant hair loss. Cisplatin alone, as given during concurrent chemoradiation, causes less hair loss than paclitaxel but may cause some thinning. When both are used together, significant hair loss is expected. Hair usually grows back after treatment ends, though the timing varies. Your oncology nurse or pharmacist can explain what to expect based on your specific regimen.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Chemotherapy Topics
Browse our complete chemotherapy guide — 1133 pages on side effects, medicines, cost, daily life and care in Hyderabad. Tap any topic to read more.